NOVEN PHARMACEUTICALS INC (NOVN) has 61 open-market insider trades by 25 insiders since 2006. The most active filer is Capital Management Oss, 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Capital Management Oss | 10% | — | 11 | $15.6M | 2009-03-04 |
| Malin Corp plc | 10% Owner | — | 1 | $8.8M | 2016-09-26 |
| Coast Asset Management Inc West | 10% | — | 1 | $2.4M | 2008-03-25 |
| Oscar Schafer | 10% | — | 4 | $2.1M | 2009-03-10 |
| Andrew J. Goffe | 10% | — | 5 | $2.1M | 2009-02-20 |
| Juan A. Mantelle | VP and Chief Technical Officer | — | 2 | $2.0M | 2007-04-12 |
| Brother Llc Schafer | 10% | — | 2 | $1.0M | 2009-03-02 |
| Peter C. Brandt | Pres | — | 2 | $493K | 2009-08-27 |
| Robert Alexander Ingram | Dir | — | 3 | $307K | 2019-05-22 |
| Diane Barrett | CFO | — | 1 | $305K | 2007-02-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| MacHelle Sanders | Director | Sell | $5K | 2023-06-27 |
| James L. Bierman | Director | Buy | $3K | 2022-04-07 |
| James L. Bierman | Director | Buy | $3K | 2022-03-28 |
| James L. Bierman | Director | Buy | $7K | 2022-03-25 |
| John M. Gay | CFO | Buy | $4K | 2022-03-18 |
| John W. Palmour | Director | Buy | $36K | 2022-03-18 |
Companies that share insiders with NOVN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| John W. Palmour | Director | Buy | $33K | 2022-03-16 |
| Paula B. Stafford | CEO & President | Buy | $100K | 2021-03-26 |
| Malin Life Sciences Holdings Ltd | 10% Owner | Sell | $68K | 2019-06-28 |
| G. Kelly Martin | CEO | Buy | $3K | 2019-05-29 |
| G. Kelly Martin | CEO | Buy | $8K | 2019-05-28 |
| John W. Palmour | Director | Buy | $44K | 2019-05-24 |
| Robert Alexander Ingram | Director | Buy | $111K | 2019-05-22 |
| W. Kent Geer | Director | Buy | $10K | 2019-05-21 |
| John M. Gay | VP & Controller | Buy | $22K | 2019-05-17 |